According to INmune Bio's latest financial reports the company's current EPS (TTM) is -$2.57. In 2022 the company made an earnings per share (EPS) of -$2.16 an increase over its 2021 EPS that were of -$2.67.
Year | EPS | Change |
---|---|---|
2024 (TTM) | -$2.44 | |
2022 | -$2.16 | -19.15% |
2021 | -$2.67 | 86.14% |
2020 | -$1.44 | 34.67% |
2019 | -$1.07 | -32.36% |
2018 | -$1.58 | 1396.12% |
2017 | -$0.11 | 199.64% |
2016 | -$0.03517 |